Advertisement

Topics

ChemGen Corp. Company Profile

07:52 EDT 21st September 2018 | BioPortfolio

ChemGen Corp. was founded in 1985 with the aim of exploring the industrial and agricultural applications of biotechnology. This differentiates ChemGen from most other biotechnology companies which are focused on human pharmaceutical applications.
ChemGen's headquarters in Gaithersburg, Maryland The company was established by a group of talented research scientists and engineers with strong technical and analytical skills. The objective of this founding group was to identify and develop a line of bio-products which ChemGen could commercialize and that would form the basis of the company's long-term success.

By late 1986, ChemGen had opened up a laboratory in the vicinity of Gaithersburg, Maryland, U.S.A. and had developed a thriving contract research business. Biotechnology R&D services were made available to large U.S., European and Japanese chemical and pharmaceutical companies. This work provided ChemGen personnel with exposure to many areas of industrial and agricultural biotechnology; the company's skills in the isolation of new microbial entities, biosynthesis pathway engineering and fermentation manufacturing blossomed. Several commercially important proprietary and patented bioprocesses were developed by ChemGen for its contract research clients.

Location

211 Perry Parkway
Gaithersburg
Maryland
20877-2144
United States of America

Contact

Phone: (301) 330-4101
Fax: (301) 948-5866
Email: info@chemgen.com


News Articles [79 Associated News Articles listed on BioPortfolio]

Korea Investment CORP Boosts Stake in Mylan

Korea Investment CORP grew its position in Mylan by 462.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 736,474 shar...

CORRECTION from Source -- Emblem Corp.

TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) -- In Emblem’s Q2 release issued 22-Aug-2018 by Emblem Corp. over GlobeNewswire, we are advised by the company that corrections were made to the Adjusted E...

GTX Corp First Quarter 2018 Summary

Revenues increased 76%, Subscribers increased 79%, G&A decreased 17% LOS ANGELES, May 16, 2018 (GLOBE NEWSWIRE) -- GTX Corp. (OTCQB:GTXO), an IoT platform and leading provider of personal loc...

GTX Corp Announces New GPS Take-Along World Tracker for $89.00

LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an IoT platform and global provider of GPS tracking and monitoring wearable and wandering assistive technology, announced toda...

GTX Corp Announces Update on Corporate Strategic Plan

LOS ANGELES, July 12, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO) (“the Company”), a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology,...

Emblem Corp. Issues President’s Letter to Shareholders

TORONTO, March 20, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) ("Emblem" or the "Corporation") provides a Letter to its Shareholders as follows: Spring is upon us, and Emblem is ...

GTX Corp Engages Doost, Inc. to Open Retail Channels

LOS ANGELES, July 19, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO) (“the Company”), a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology,...

Emblem Corp. Reports 2018 First Quarter Results

Strengthened team, new products, and key distribution partnerships driving demand NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, May 2...

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Companies [42 Associated Companies listed on BioPortfolio]

ChemGen Corporation

ChemGen is a privately held biotechnology company specializing in developing products through the use of microbial fermentation technology. ChemGen's focus has been on the production of enzymes for ...

ChemGen Corp.

ChemGen Corp. was founded in 1985 with the aim of exploring the industrial and agricultural applications of biotechnology. This differentiates ChemGen from most other biotechnology companies which are...

CHEMGEN Pharma International

CHEMGEN Pharma International is a Contract Research Organization serving the global pharmaceutical and biotechnology companies with innovative chemistry expertise, reliable and fl...

NORLOFF COMPUTER CORP

Nil

ATLANTIS DRUG CORP

Nil

More Information about "ChemGen Corp." on BioPortfolio

We have published hundreds of ChemGen Corp. news stories on BioPortfolio along with dozens of ChemGen Corp. Clinical Trials and PubMed Articles about ChemGen Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ChemGen Corp. Companies in our database. You can also find out about relevant ChemGen Corp. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record